PAKIANATHAN DEEPIKA 4
4 · Karyopharm Therapeutics Inc. · Filed May 29, 2025
Insider Transaction Report
Form 4
PAKIANATHAN DEEPIKA
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2025-05-28+4,600→ 4,600 totalExercise: $4.48Exp: 2035-05-27→ Common Stock (4,600 underlying)
Footnotes (2)
- [F1]Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025.
- [F2]This option vests as to 100% of the underlying shares on May 28, 2026.